Skip to main content
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. logo

CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. — Investor Relations & Filings

Ticker · 000661 ISIN · CNE0000007J8 LEI · 300300X04OTKZG18WD66 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,288 across all filing types
Latest filing 2020-06-15 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000661

About CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD.

https://ccht.jl.cn

CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. is a diversified enterprise primarily focused on the research, development, production, and distribution of biopharmaceuticals and healthcare products. The company operates through several key subsidiaries, most notably GeneScience Pharmaceuticals, which specializes in recombinant human growth hormones and pediatric endocrinology treatments. Its product portfolio includes biological drugs, vaccines, and traditional Chinese medicines, targeting therapeutic areas such as growth disorders, infectious diseases, and oncology. The group emphasizes technological innovation and maintains a significant presence in the domestic market while expanding its international footprint. In addition to its core life sciences business, the company maintains interests in real estate development and infrastructure management.

Recent filings

Filing Released Lang Actions
2020年第一次临时股东大会之法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the legality of the procedures and results of a company's 2020 first extraordinary general meeting (临时股东大会). It details the convening, attendance, voting procedures, and results of the shareholders' meeting. The document does not contain financial statements or financial performance data, nor is it a report of financial results or management discussion. It is not an announcement of voting results but a legal opinion on the meeting's legality. Given the content focuses on the legal opinion related to a shareholders' meeting, it aligns best with a Regulatory Filings (RNS) category, which covers miscellaneous regulatory announcements and compliance documents that do not fit other categories. The document length is under 5,000 characters, but it is a substantive legal opinion, not a mere announcement of a report publication. Therefore, the classification is RNS with high confidence.
2020-06-15 Chinese
2020年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement from the 2020 first extraordinary shareholders' meeting of Changchun High-tech Industry (Group) Co., Ltd. It details the meeting date, voting methods, attendance, voting results, and legal opinions confirming the validity of the meeting and resolutions. The content focuses on the announcement of the voting results and the resolution passed at the shareholders' meeting. The document length is short (1799 characters) and it does not contain financial statements or detailed financial analysis. It is not a full report but an official announcement of the voting results from a shareholders' meeting. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2020-06-15 Chinese
公司章程（2020年6月）
Governance Information Classification · 95% confidence The document is a detailed company charter or articles of association (章程) for Changchun High & New Technology Industries (Group) Inc., including comprehensive sections on company governance, shareholder rights, board structure, share issuance, shareholder meetings, and internal party committee roles. It references Chinese company law and securities law, and covers governance rules, shareholder meeting procedures, board and management roles, and share capital details. The document is lengthy (15,000 characters) and contains no financial statements, earnings data, or audit opinions. It is not an announcement or a brief notice but a full governance document outlining the company's internal rules and structure. Therefore, it fits the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2020-06-11 Chinese
关于分拆所属子公司长春百克生物科技股份公司至科创板上市的预案（修订稿）
Capital/Financing Update Classification · 95% confidence The document is a detailed proposal regarding the spin-off and listing of a subsidiary company (Changchun Baike Biotechnology Co., Ltd.) on the Shanghai Stock Exchange's STAR Market (科创板). It includes extensive information about the spin-off plan, background, business rationale, financial data, regulatory compliance, and risk disclosures. The document is titled as a "预案 (修订稿)" which translates to a "proposal (revised draft)" for the spin-off listing. It is not a full financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a simple announcement or voting result. It is a comprehensive plan document related to a capital market transaction involving a subsidiary's IPO. This type of document aligns best with the category of Capital/Financing Update (CAP), as it provides detailed information on the company's financing activity and capital structure changes through the spin-off and listing of a subsidiary. The document length (15,000 characters) and content depth confirm it is not a brief announcement or regulatory filing. Therefore, the appropriate classification is CAP with high confidence.
2020-06-11 Chinese
北京国枫律师事务所关于公司分拆所属子公司长春百克生物科技股份公司至上海证券交易所科创板上市的法律意见书
Regulatory Filings Classification · 95% confidence The document is a detailed legal opinion letter issued by a law firm regarding the spin-off and listing of a subsidiary company (Changchun Baike Biotechnology Co., Ltd.) of Changchun High-tech Industry (Group) Co., Ltd. on the Shanghai Stock Exchange Science and Technology Innovation Board (科创板). It includes extensive legal analysis, compliance with relevant laws and regulations, audit reports references, financial data summaries, and approvals from board meetings. The document is a formal legal opinion supporting the spin-off listing process, which is a specialized legal and regulatory filing related to corporate restructuring and capital market activities. It is not an annual report, audit report, earnings release, or other financial report but a legal opinion letter specifically for the spin-off listing. This type of document fits best under the category of Regulatory Filings (RNS) as it is a regulatory compliance document that does not fit other specific categories like M&A filings or capital/financing updates. The document length (15,000 characters) and content confirm it is not a brief announcement or a report publication announcement but a substantive legal opinion document.
2020-06-11 Chinese
关于分拆子公司上市的一般风险提示性公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by Changchun High-tech Industry Group Co., Ltd. regarding the planned spin-off and listing of its subsidiary on the Shanghai Stock Exchange's STAR Market. It discusses the board meeting approval, regulatory conditions, and risks related to the spin-off. The document is short (757 characters) and serves as a risk warning and procedural update rather than a detailed financial report or formal filing like a merger or capital change. It does not contain financial statements or detailed transaction data. This fits best under Capital/Financing Update (CAP) as it relates to a corporate restructuring and capital market activity (spin-off and listing).
2020-06-11 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.